MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-OD-19-0026571
Elipis Pharmaceuticals Private Limited
Elipis Pharmaceuticals Private Limited - pharma in Bhubaneswar, Odisha, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹83,000
▼ 60% YoY
Net loss · FY 2024
₹19,000
Net margin -22.9%
EBITDA · FY 2024
-₹6,000
EBITDA margin -7.2%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Elipis Pharmaceuticals Private Limited
Data last updated:
Elipis Pharmaceuticals Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24299OR2019PTC031933. Its GSTIN is 21AAFCE6856N1ZA (Odisha).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Sanghamitra Pradhan and Sikha Suman.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at House No – 10 Plot No – 645 12th Mile Stone Jhandagiri Kalinga Nagar, Bhubaneswar, Odisha, India – 751019.
As per the financials filed for FY 2024, the company reported a revenue of ₹83,000, a decline of 60% compared to the previous year. For the same year it recorded a net loss of ₹19,000 (net margin -22.9%) and EBITDA of -₹6,000 (EBITDA margin -7.2%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years.
Elipis Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-OD-19-0026571).
Company details
CIN U24299OR2019PTC031933
Registration Number 031933
Incorporation Date 25 October 2019
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-OD-19-0026571
Recognitions & Rankings of Elipis Pharmaceuticals
Contact details
Elipis Pharmaceuticals Private Limited's registered office is in Bhubaneswar, Odisha. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No – 10 Plot No – 645 12th Mile Stone Jhandagiri Kalinga Nagar, Bhubaneswar, Odisha, India – 751019
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Elipis Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Elipis Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Elipis Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Elipis Pharmaceuticals Private Limited, buy the company report.
Financials of Elipis Pharmaceuticals Private Limited
FY 2024 filings availableElipis Pharmaceuticals Private Limited reported revenue of ₹83,000 (down 60% YoY) for FY 2024.
Revenue · FY 2024
₹83,000 ▼ 60%
Net loss · FY 2024
₹19,000 margin -22.9%
EBITDA · FY 2024
-₹6,000 margin -7.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 60%
3 years · compounded
▼ 21%
EBITDA CAGR growth
1 year
▼ 122%
3 years · compounded
▼ 210%
Revenue has declined at a compounded annual rate (CAGR) of 21% over three years, including a 60% fall in the latest year. EBITDA fell 122% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6,000 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹19,000 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -7.2% | ||||
| Net Profit Margin | -22.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Elipis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Elipis Pharmaceuticals Private Limited
Elipis Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanghamitra Pradhan | Director | 25 Oct 2019 | 6 Years 11 Months | Current |
| Sikha Suman Also directs: Agnirupa Construction Private Limited | Director | 25 Oct 2019 | 6 Years 11 Months | Current |
| Pradeep Kumar Pal | Director | 25 Oct 2019 | 6 Years 11 Months | Current |
Auditor
Elipis Pharmaceuticals Private Limited is audited by MKPS & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MKPS & ASSOCIATES | FY 2023 | 302014E |
Shareholding
The shareholding of Elipis Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Elipis Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Elipis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elipis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Elipis Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAFCE6856N1ZA | Odisha | Active | 05 Nov 2019 |
To see the full GST registrations and return filing status of Elipis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Elipis Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Pradeep Kumar Pal was appointed as Director on 25 Oct 2019.
AGM
Elipis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Elipis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Cuttack.
Appointed
Pradeep Kumar Pal was appointed as Director.
Appointed
Sanghamitra Pradhan was appointed as Director.
Appointed
Sikha Suman was appointed as Director.
Incorporation
25 Oct 2019
Elipis Pharmaceuticals Private Limited was registered on 25 Oct 2019 with Roc Cuttack & aged 6 years 11 months as per MCA records.
Frequently asked questions
Elipis Pharmaceuticals is an active private limited company based in Bhubaneswar, Odisha, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 October 2019 (7+ years old) and is registered under CIN U24299OR2019PTC031933.
Elipis Pharmaceuticals has 3 current directors:
- Sanghamitra Pradhan - Director
- Sikha Suman - Director
- Pradeep Kumar Pal - Director
The latest financial statements of Elipis Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Elipis Pharmaceuticals is 21AAFCE6856N1ZA, registered in Odisha.
The CIN (Corporate Identification Number) of Elipis Pharmaceuticals is U24299OR2019PTC031933. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elipis Pharmaceuticals was incorporated on 25 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Cuttack.
Pradeep Kumar Pal was appointed as Director on 25 Oct 2019. Sanghamitra Pradhan was appointed as Director on 25 Oct 2019. Sikha Suman was appointed as Director on 25 Oct 2019.
Yes, Elipis Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-OD-19-0026571).
The registered office of Elipis Pharmaceuticals is at House No – 10 Plot No – 645 12th Mile Stone Jhandagiri Kalinga Nagar, Bhubaneswar, Odisha, India – 751019.
Elipis Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.